News

Zacks Investment Research on MSN22h
Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock?
Novo Nordisk NVO shares have lost 16.7%, attributable to both sector-specific developments and broader macroeconomic ...
Zacks Investment Research on MSN23h
Eli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Eli Lilly (LLY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is ...